A PYMNTS Company

CVS and Rite Aid file charges against Wyeth and Teva over Effexor pay-for-delay

By  |  June 13, 2012

CVS and Rite Aid have filed an antitrust lawsuit against Wyeth and Teva in New Jersey federal court. The pharmacies allege that the two drug manufacturers conspired to keep generics of Effexor XR off the market and agreed to prolong Teva’s generic exclusivity rights. The complaint also accuses Wyeth of obtaining fraudulent patents and engaging in sham litigation.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Walgreen and other retailers filed a similar complaint against Wyeth and Teva in December 2011.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full content: Reuters

     

    Related content: Whistling Past the Graveyard: The Problem with the Per Se Legality Treatment of Pay-For-Delay Settlements (Michael Kades, FTC)

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.